722
Views
7
CrossRef citations to date
0
Altmetric
Review Articles

Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances

, , &
Pages 14279-14302 | Received 18 Aug 2021, Accepted 16 Oct 2021, Published online: 15 Nov 2021
 

Abstract

Imidazopyridine scaffold has gained tremendous importance over the past few decades. Imidazopyridines have been expeditiously used for the rationale design and development of novel synthetic analogs for various therapeutic disorders. A wide variety of imidazopyridine derivatives have been developed as potential anti-cancer, anti-diabetic, anti-tubercular, anti-microbial, anti-viral, anti-inflammatory, central nervous system (CNS) agents besides other chemotherapeutic agents. Imidazopyridine heterocyclic system acts as a key pharmacophore motif for the identification and optimization of lead structures to increase medicinal chemistry toolbox. The present review highlights the medicinal significances of imidazopyridines for their rationale development as lead molecules with improved therapeutic efficacies. This review further emphasis on the structure–activity relationships (SARs) of the various designed imidazopyridines to establish a relationship between the key structural features versus the biological activities.

Communicated by Ramaswamy H. Sarma

Acknowledgments

The authors are thankful to Prof. Prasad V. Bharatam, Professor Medicinal Chemistry at NIPER Mohali, for constant support and encouragement.

Disclosure statement

No potential conflict of interest was reported by the authors.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.